IX Biopharma Ltd (IXBI)

Singapore
0.235
-0.005(-2.08%)
  • Volume:
    218,300
  • Bid/Ask:
    0.235/0.235
  • Day's Range:
    0.235 - 0.24

IXBI Overview

Prev. Close
0.24
Day's Range
0.235 - 0.24
Revenue
1.52M
Open
0.24
52 wk Range
0.21 - 0.35
EPS
-0.01
Volume
218,300
Market Cap
163.76M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,014,766
P/E Ratio
-
Beta
1.04
1-Year Change
-14.55%
Shares Outstanding
696,853,023
Next Earnings Date
May 13, 2021
What is your sentiment on IX Biopharma Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsNeutralSellStrong SellStrong SellSell
SummarySellStrong SellStrong SellStrong SellSell

IX Biopharma Ltd Company Profile

IX Biopharma Ltd Company Profile

Employees
56
Market
Singapore

iX Biopharma Ltd. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction. Its segments include Specialty Pharmaceutical and Chemical Analysis segments. The Specialty Pharmaceutical segment is engaged in the development, manufacturing and sale of pharmaceutical products. The Chemical Analysis segment is engaged in the provision of laboratory testing services. Its products are Wafermine, which is a sublingual ketamine oral wafer that contains the non-opioid drug for the management of moderate to severe pain; Bnox, which is a sublingual buprenorphine oral wafer that is developed as a formulation for moderate to severe pain; PheoniX, which is used for the treatment of male erectile dysfunction; WaferRest, which is used for the alleviation of jet lag and improving sleep quality, and Wafernyl, which is used for breakthrough cancer pain.

Read More
  • Is it good to hold this long term?
    0
    • Downtrend triangle at 0.370
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.